Showing results (61-70 of 128) with videos related to
Sort By:
Pageof 13
Clinical Lymphoma & Myeloma|November 21, 2007
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka, Sarah Newton, Bernice M Benoit, et al.Journal of the American Academy of Dermatology|August 12, 2009
Extracorporeal photopheresis: past, present, and futureRobert Knobler, Mark L Barr, Daniel R Couriel, et al.Journal of the American Academy of Dermatology|April 26, 2006
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosisRobert M Knobler, Lars E French, Youn Kim, et al.Archives of Dermatology|August 8, 2002
Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institutionKaren Rebecca Suchin, Andrew J Cucchiara, Scott L Gottleib, et al.American Journal of Hematology|February 28, 2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patientsMichael J Kelly-Sell, Youn H Kim, Suzanne Straus, et al.Leukemia & Lymphoma|March 21, 2015
Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphomaEllen J Kim, Youn H Kim, Alain H Rook, et al.The Journal of Biological Chemistry|January 22, 2002
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6David A Shapiro, Kurt Kristiansen, David M Weiner, et al.Molecular Pharmacology|February 24, 2004
Loss-of-function polymorphic variants of the human angiotensin II type 1 receptorJakob Lerche Hansen, Stig Haunsø, Mark R Brann, et al.American Journal of Hematology|June 5, 2007
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokineStephen K Richardson, Sarah B Newton, Tami L Bach, et al.The Journal of Investigative Dermatology|June 25, 2013
CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patientsMaria Wysocka, Andrew V Kossenkov, Bernice M Benoit, et al.Pageof 13